Product image of Norditropin Nordiflex (Somatropin) supplied by GNH India

Norditropin Nordiflex

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Nordiflex (Somatropin)

Somatropin, the active ingredient in Norditropin Nordiflex, is a recombinant human growth hormone presented as an injectable solution for subcutaneous administration. It is used to replace deficient endogenous growth hormone and to support growth in pediatric and adult patients with specific endocrine or genetic conditions.

GNH India supplies Norditropin Nordiflex as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide. The company ensures quality compliance with EU standards and offers reliable cold‑chain logistics for this biologic therapy.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Nordiflex, a recombinant growth hormone, is indicated for conditions related to growth hormone deficiency and associated growth disorders.

  • Growth hormone deficiency: stimulates linear growth and improves metabolic parameters in children and adults with confirmed deficiency.
  • Turner syndrome: promotes height gain and improves body composition in girls with this chromosomal disorder.
  • Chronic renal insufficiency: enhances growth velocity in pediatric patients with renal disease.
  • Prader‑Willi syndrome: supports growth and body composition in affected individuals.
  • Idiopathic short stature: increases height potential in children with unexplained short stature.

How It Works

  • Somatropin binds to growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling pathway. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators, leading to increased protein synthesis, cell proliferation, and linear bone growth, while also influencing metabolism of carbohydrates and lipids.

Side Effects

Common Side Effects

  • Injection site pain or erythema: mild discomfort at the injection site.
  • Headache: transient and usually mild.
  • Joint stiffness or arthralgia: may occur during growth spurts.
  • Edema: peripheral swelling, often mild.
  • Hyperglycemia: elevated blood glucose, especially in predisposed patients.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include headache, visual disturbances, and nausea.
  • Slipped epiphysis (growth plate injury): risk of bone fracture at growth plates.
  • Severe allergic reaction: rash, urticaria, or anaphylaxis.
  • Increased risk of malignancy: monitor for tumor growth in susceptible individuals.
  • Cardiomyopathy: rare cardiac dysfunction.

Precautions & Warnings

Before initiating therapy, clinicians should assess relevant medical history and monitor ongoing parameters.

  • Monitor glucose levels: patients with diabetes may experience hyperglycemia.
  • Assess intracranial pressure: watch for signs of increased pressure.
  • Screen for malignancy: avoid use in active cancer patients.
  • Adjust dose in renal impairment: consider reduced clearance.
  • Avoid use in active malignancy: contraindicated due to proliferative potential.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin may interact with several medications that affect its efficacy or safety.

Major Interactions (Avoid)

  • Glucocorticoids: can antagonize growth hormone effects and reduce IGF‑1 response.
  • Oral estrogen therapy: may diminish IGF‑1 production and blunt growth response.
  • Insulin: concurrent use may increase risk of hypoglycemia.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: may require dose adjustment based on metabolic changes.
  • Diabetes medications (e.g., metformin, sulfonylureas): monitor blood glucose closely.
  • Antidiabetic sulfonylureas: increased risk of hypoglycemia, require monitoring.

Frequently Asked Questions

Norditropin Nordiflex is prescribed for patients with growth hormone deficiency, Turner syndrome, chronic renal insufficiency, Prader‑Willi syndrome, and idiopathic short stature. In each case, the therapy aims to replace deficient growth hormone, promote linear growth, and improve metabolic outcomes.

Somatropin is a recombinant form of human growth hormone that binds to specific growth hormone receptors on cell surfaces. This binding activates intracellular signaling pathways, leading to increased production of insulin‑like growth factor‑1 (IGF‑1), which drives protein synthesis, bone growth, and metabolic regulation.

The dose of Norditropin Nordiflex is individualized and determined by the prescribing physician based on the patient’s age, weight, underlying condition, and IGF‑1 response. Patients should follow the exact dosing instructions provided by their healthcare professional.

The safety of somatropin during pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.

Norditropin Nordiflex is a recombinant human growth hormone formulated as an injectable solution for subcutaneous use, similar to other somatropin products. Differences may lie in device design, stability profile, and approved indications, but the active molecule and mechanism of action are comparable across brands.

Norditropin Nordiflex must be stored in a refrigerator at 2‑8 °C. It should be kept in its original packaging, protected from light, and must not be frozen or shaken. Once in use, the vial can be kept at room temperature for a limited period as indicated in the product label.

The medication is administered by subcutaneous injection, typically into the thigh, abdomen, or upper arm. Patients or caregivers should be trained on proper injection technique, site rotation, and aseptic handling to ensure accurate dosing and minimize injection‑site reactions.

Serious risks include intracranial hypertension, slipped epiphysis (growth‑plate injury), severe allergic reactions, and potential acceleration of tumor growth in patients with active malignancies. Regular monitoring of growth parameters, visual symptoms, and overall health is essential during therapy.

Norditropin Nordiflex is contraindicated in patients with active malignancy, known hypersensitivity to somatropin or any excipients, and those with acute critical illness due to complications of severe chronic disease. It should also be used with caution in individuals with uncontrolled diabetes or severe renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT